Research & Transparency — Semenax

Clinical Study: Effect of Semenax Capsules on Semen Characteristics

Semenax is one of the few semen volume supplements backed by a product-specific clinical trial. This section provides full transparency on the study design, findings, and limitations.

Protocol ID: DM/100710/SMX/MSD

Conducted by: Vedic Lifesciences Pvt. Ltd.

Study Design: Randomized, double-blind, placebo-controlled trial

Participants: 63 evaluable cases in the per-protocol (PP) population; 78 in the intention-to-treat (ITT) population

Key Findings

  • Ejaculate volume: The Semenax group showed a mean increase of +0.49 mL compared to a decrease of -0.21 mL in the placebo group (p = 0.0008)
  • Clinical responders: 50% of Semenax users showed a 20% or greater increase in semen volume, compared to only 16% in the placebo group (p = 0.004)
  • Investigator global assessment: Investigators rated Semenax as superior to placebo for overall semen characteristic improvement (p = 0.02)
  • Patient-reported volume improvement: Participants in the Semenax group reported significantly greater subjective improvement in semen volume compared to placebo (p = 0.0001)

Study Strengths

  • Randomized, double-blind, placebo-controlled design (gold standard for supplement research)
  • Statistically significant results across multiple endpoints (all p < 0.05)
  • Both objective measurements and subjective assessments showed consistent improvement
  • Conducted by an independent contract research organization (Vedic Lifesciences)
  • Per-protocol and intention-to-treat analyses both support the findings

Study Limitations

  • Single study — results have not been independently replicated in a separate trial
  • Funded by the manufacturer (standard for supplement research, but noted for transparency)
  • Moderate sample size (63 PP, 78 ITT)
  • Specific participant criteria may not represent all potential users
  • Long-term outcomes beyond the study period are not established

Official Clinical Study Page: View on Official Website

Key Ingredient Research References

The following references support the scientific basis for key ingredients in the Semenax formulation:

L-Arginine and Nitric Oxide

Roberts M, Bhatt B, Engelman G, Jarvi K. The role of nitric oxide in male reproductive health. 2009.

L-Arginine is a direct precursor to nitric oxide, which plays a critical role in vascular function and blood flow to reproductive organs. Nitric oxide signaling supports the vascular mechanisms involved in sexual function and may contribute to the physiological processes underlying semen production and ejaculation. Adequate L-Arginine availability supports the NO-mediated pathways essential for healthy male reproductive function.

Zinc and Semen Parameters

Kumar N, Verma RP, Singh LP, Varshney VP, Dass RS. Effect of different levels and sources of zinc supplementation on quantitative and qualitative semen attributes and serum testosterone level in crossbred cattle bulls. Reproduction, Nutrition, Development, 2006; 46(6): 663–675.

Zinc is an essential trace mineral for male reproductive health, playing a documented role in testosterone metabolism, spermatogenesis, and semen quality. Adequate zinc status is associated with healthy semen parameters including volume, concentration, and motility. Zinc deficiency is linked to reduced semen quality in multiple studies.

L-Carnitine and Male Fertility

Moradi M, Moradi A, Alemi M, et al. Safety and efficacy of L-carnitine supplementation in male infertility: a systematic review and meta-analysis. 2010.

L-Carnitine is involved in cellular energy metabolism and has been studied for its role in supporting sperm quality, motility, and overall male reproductive function. Supplementation has shown potential benefits for semen parameters in clinical research, particularly in men with suboptimal baseline values.

Maca and Male Reproductive Function

Gonzales GF, Cordova A, Vega K, et al. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia, 2001; 34: 367–372.

Maca (Lepidium meyenii) has been traditionally used to support sexual desire and reproductive function. Clinical research has shown that maca supplementation can improve subjective measures of sexual desire without directly altering serum testosterone levels, suggesting alternative mechanisms of action related to adaptogenic and neuroendocrine pathways.

How We Use This Research

These references inform — but do not solely determine — our editorial analysis. We use clinical data to:

  1. Evaluate whether Semenax’s claimed benefits have supporting evidence
  2. Assess whether ingredient doses are within ranges studied in research
  3. Provide readers with verifiable sources they can review independently
  4. Maintain editorial accountability and transparency

We present both the evidence that supports Semenax and the limitations of that evidence. Our goal is transparency, not advocacy.

Interpretation Principles

  • Clinical evidence supports biological plausibility — The Semenax clinical study and ingredient research provide a reasonable scientific foundation for the product’s positioning
  • Individual responses will vary — Outcomes depend on age, health status, lifestyle factors, and consistency of use
  • A single study is not definitive — We note the strength of the evidence while acknowledging that independent replication would strengthen the case further
  • Consult a healthcare provider — Clinical data does not replace personalized medical guidance

Readers are encouraged to review these sources directly and discuss any supplement decisions with a qualified healthcare professional.